Digital visual tool to help patients, caregivers, and providers understand cancer treatment options and improve the care experience
Official title: Visual Communication: Can a Digital Tool Improve the Understanding of Treatment Options for Patients With Cancer and Increase Satisfaction of the Overall Experience for Patients, Caregivers, and Providers?
Run by NYU Langone Health · NCT06927050 · Data updated 2026-11-12
This trial will try a digital visual communication tool with adults newly diagnosed with breast or head and neck cancer (and their caregivers and oncology providers) to see if it improves understanding and overall satisfaction with care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 86 (estimated) |
| Sponsor | NYU Langone Health Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | April 21, 2025 |
| Main results expected | April 1, 2026 |
| Study ends | April 1, 2026 |
| Registry record updated | February 25, 2026 |
| Trial ID | NCT06927050 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–100 with newly diagnosed breast or head and neck cancer who are English-speaking, planned for definitive-intent treatment, seen at NYU Langone during the recruitment window, and able to give consent (with any adult caregiver willing to consent) are ideal candidates.
✕Probably not a fit
Patients who are non-English-speaking, have cancer at sites other than breast or head and neck, are receiving palliative rather than definitive-intent treatment, or are treated outside NYU Langone are unlikely to benefit from this tool in this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective interventional study integrates a digital visual communication tool into consultations for adults with newly diagnosed breast or head and neck cancer at NYU Langone Health. The tool is used during visits involving patients, any participating caregivers, and oncology or ENT providers, and is intended for patients being treated with definitive intent. The study measures feasibility of integration and whether use of the tool increases overall satisfaction with the patient experience among patients, caregivers, and providers. Participation is limited to English-speaking adults seen in consultation between December 1, 2024 and June 1, 2025 at the NYU Langone site.
Why it matters
Potential benefit: If successful, the tool could improve patient and caregiver understanding of treatment choices and increase satisfaction with the care experience, potentially leading to clearer decision-making and better communication among care teams.
How similar studies have gone: Prior research using visual decision aids in oncology has sometimes improved patient understanding and satisfaction, though digital tools that integrate patients, caregivers, and providers at the point of consultation are less extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients: * Patients seen in consultation from 12/1/2024-6/1/2025 * Patients aged 18 years to 100 years old * Patients with a malignancy of breast or head and neck * English speaking patients * Patients being treated with definitive intent * Patients treated at NYU Langone Health for their malignancy * Willing and able to provide consent Caregivers: * Any adult caregiver(s) (aged 18 years to 100 years old) to a patient who fulfills the inclusion and exclusion criteria above. * Willing and able to provide consent Providers: * Doctors and nurse practitioners in medical oncology and radiation oncology, and in the ear nose throat (ENT) department. * Willing and able to provide consent * aged 18 years to 100 years old Exclusion Criteria: Patients: * Patients with any other site of disease other than listed above * Non-English-speaking patients, as the tool is currently available in English only. Translation into additional languages such as Spanish and Russian is currently in process. * Patient unable to complete the survey portion of the study independently Caregivers: • Unable to complete the survey portion of the study independently
Where it's running
-
NYU Langone Health
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Jason Domogauer, MD, PhD — NYU Langone Health
- Study coordinator: Jason Domogauer, MD, PhD
- Email: Jason.Domogauer@nyulangone.org
- Phone: (212) 501-5003
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Medial unloader brace after root repair
This study tests whether using a medial unloader brace after arthroscopic medial meniscus posterior root repair helps healing and improves knee outcomes.
-
MAC-STILA: a feasibility test for hip fracture surgery anesthesia
This trial tests whether combining monitored anesthesia care with soft tissue infiltration using local anesthesia can reduce post-operative delirium in adults 65 and older undergoing hip fracture repair.
-
Osimertinib with Cyclosporine A for EGFR-mutant NSCLC
This phase II study tests whether adding cyclosporine A to osimertinib helps people with EGFR-mutant metastatic NSCLC who still have detectable tumor DNA in blood.
-
Histotripsy with chemotherapy and immunotherapy for biliary tract cancer
This pilot test will see if adding histotripsy to chemoimmunotherapy is safe and feasible for adults with biliary tract cancer.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
Virtual Reality Vision Testing for Metamorphopsia and Aniseikonia
A portable virtual reality headset is tested to see if it can more reliably and conveniently measure visual distortions in people with metamorphopsia or aniseikonia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.